InstalabCardioIQ Insulin Resistance Panel
Should you take a CardioIQ Insulin Resistance Panel test?
This test is most useful if any of these apply to you.
3 Biomarkers Included
- Intact InsulinMeasures how much insulin is actually circulating. High fasting insulin is one of the earliest signs your body is working overtime to move sugar into cells that respond weakly.Elevated fasting insulin frequently appears while glucose still looks normal, marking the earliest detectable stage of insulin resistance.
- C-PeptideReleased by the pancreas alongside insulin but cleared more slowly, so it gives a steadier picture of how much insulin your body is truly producing.High C-peptide points to a hard-working pancreas, while unusually low levels can signal that its output is fading.
- CardioIQ Insulin Resistance ScoreBlends your insulin and C-peptide into one number designed to classify insulin resistance more accurately than an insulin reading alone, giving you a single read on early metabolic risk.A high score suggests your cells are resisting insulin and your pancreas is compensating, often years before blood sugar climbs.
About CardioIQ Insulin Resistance Panel
Long before blood sugar drifts high, your body fights to keep it normal by releasing extra insulin. That silent effort can run for years while a routine glucose test still reads fine.
This panel is built to see that effort directly. It measures the two hormones your pancreas uses to manage sugar and folds them into a single score designed to flag insulin resistance early, showing not just whether your sugar is normal but how much work it takes to keep it there.
What This Panel Reveals
Insulin resistance means your cells respond weakly to insulin, so the pancreas compensates by producing more. This panel reads that compensation from three angles rather than one, which is where its value lies. A single hormone reading can mislead, but three related signals together tell a fuller story.
The first angle is how much insulin is circulating. High fasting insulin is one of the earliest signs your body is compensating, and it often rises while glucose still looks completely normal. The second angle comes from C-peptide, a molecule your pancreas releases in equal amounts to insulin but that clears more slowly and is not extracted by the liver on its first pass. That makes C-peptide a steadier gauge of how much insulin your body is genuinely making.
The third angle is the CardioIQ Insulin Resistance Score, which combines the two hormone readings into one number. In a formula validated against a direct insulin suppression test, this insulin-plus-C-peptide approach classified insulin resistance more accurately than insulin readings interpreted alone. Emerging evidence suggests this combination adds signal that either marker misses on its own, though standardized interpretation frameworks are still evolving. Major diabetes guidelines still do not recommend routine insulin or C-peptide testing for risk screening, viewing these measures as primarily research tools, so treat this panel as an early signal to discuss rather than a stand-alone diagnostic test.
How to Read Your Results Together
The patterns between these three results matter more than any single value. Because insulin is cleared quickly by the liver while C-peptide is not, comparing them helps separate how much your pancreas is producing from how much your liver is clearing. Use the patterns below as a starting point for conversation, not a diagnosis.
| Pattern | What It May Suggest |
|---|---|
| High insulin, high C-peptide, high score | Your pancreas is overproducing to overcome resistant cells, the classic early insulin resistance pattern, even if glucose is normal. |
| High insulin, relatively low C-peptide | Your liver may be clearing less insulin than usual, so circulating insulin looks higher than actual output. |
| Low insulin, low C-peptide, higher glucose | Pancreatic output may be fading rather than compensating, a different problem that warrants prompt follow-up. |
| All three in range | Your cells are currently responding well to insulin, a reassuring metabolic sign worth confirming over time. |
What to Do with Your Results
If your score points toward insulin resistance, the next step is context. Adding a three-month blood sugar average (HbA1c), fasting triglycerides, and waist measurement helps confirm whether the pattern is affecting glucose and lipids yet. These markers matter because the risk is real: in one large trial, each standard-deviation increase in a combined insulin and C-peptide score was linked to 25% higher odds of coronary heart disease (adjusted odds ratio 1.25, 95% confidence interval 1.04 to 1.50).
Because these hormones swing day to day, one draw is a snapshot, not a verdict. Retest in three to six months after any meaningful change to diet, weight, activity, or medication, and track the direction rather than fixating on a single number. If results are strongly abnormal or you have kidney disease, a hormone condition, or a strong family history, share them with a clinician who can weigh them against your glucose, lipids, and blood pressure.
When Results Can Be Misleading
A few factors distort all three results at once, so read them with care. A non-fasting sample, a recent carbohydrate-heavy meal, acute illness, or short-term stress can push insulin and its score up temporarily. Reduced kidney function is important too, because C-peptide is cleared by the kidneys and can read falsely high when filtration slows.
Lab technique is a real limit as well. Insulin and C-peptide assays are not standardized across laboratories. The same C-peptide sample can read up to 38% differently between methods, and insulin can vary even more, while C-peptide levels shift roughly 24% within the same person from day to day. For that reason, track your trend using the same lab whenever possible rather than comparing single values across providers.